Search Results

Search

Ethics Talk: Vaccine Ethics and the Novel Coronavirus (SARS-CoV-2)

Submitted by gale.saulsberr… on Fri, 07/24/2020 - 13:37

In this video and audio edition of Ethics Talk, journal editor in chief, Audiey Kao, MD, PhD, talks with Arthur Caplan, PhD, about the development, production, and use of potential vaccines against the novel coronavirus or SARS-CoV-2.

Click here to read the transcript.

Arthur Caplan, PhD is the head of the Division of Medical Ethics at New York University Grossman School of Medicine.

Video

 

Infectious Disease Patient Care

Audio

 

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image videocast4-2005 Issue Sharing Health Decisions Videocast CME Off

Ethics Talk: Publishing Science and Accelerating Discovery During and After COVID-19

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Drs Stefano Bertozzi and Jeffrey Mackie-Mason about sustainable models of scientific publishing that advance biomedical knowledge and discovery. 

Click here to read the transcript.

Stefano Bertozzi, MD, PhD is a professor of health policy and management at the UC Berkeley School of Public Health, and editor in chief of Rapid Reviews: COVID-19.

Jeffrey Mackie-Mason, PhD, MPP is a professor at the UC Berkeley School of Information and Department of Economics, and university librarian and chief digital scholarship officer at UC Berkeley.

Video

 

Audio

 

Conflict of Interest Disclosure
Interviewees had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Behavioral Architecture in Health Care Videocast CME Off

Ethics Talk: Unblinding COVID-19 Vaccine Trials

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Steven Goodman about the ethical and scientific implications of unblinding COVID-19 vaccine trials.

Click here to read the transcript.

Steven Goodman, MD, MHS, PhD is Associate Dean of Clinical and Translational Research and Professor of Medicine and of Epidemiology and Population Health at Stanford School of Medicine.

Video

 

Audio

 

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Legacies of the Holocaust in Health Care Videocast CME Off

Ethics Talk: Equity and Intellectual Property Protection of COVID Vaccines

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Prof Ana Santos Rutschman about the impact of intellectual property regimes on domestic and global responses to the COVID-19 pandemic.

Click here to read the transcript. 

Ana Santos Rutschman, SJD is an assistant professor of law at the Saint Louis University School of Law.

Video

Recorded on April 28, 2021

 

Audio

 

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Ending the HIV Epidemic Videocast CME Off

Ethics Talk: Could Trusting Science Mean Not Trusting Some FDA Decisions?

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Caleb Alexander about the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.

Click here to read the transcript.

G. Caleb Alexander, MD, MS is professor of epidemiology and medicine at Johns Hopkins Bloomberg School of Public Health.

Video

Recorded on June 22, 2021

 

Neurology Patient Care

Audio

 

Conflict of Interest Disclosure

Dr Alexander is past chair and current member of FDA's Peripheral and Central Nervous System Drugs Advisory Committee. He is a co-founding principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation. He was also a member of OptumRx's National Pharmacy and Therapeutics Committee.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Visibility and Measurability in Health Care Videocast Off